Empirical models can be constructed relating the change in toxicity to the change in chemical structure for series of similar compounds or mixtures. The first step is to translate the variation in structure to quantitative numbers. This gives a data table, a data matrix denoted by X, which then is analyzed. The same type of the models can be used to relate the variation of in vivo data to the variation of a battery of in vitro tests.
Introduction
Pattern recognition (henceforth briefly PARC) and related multivariate data analytical methods have recently been applied to the problem of predicting the biological activity of chemical compounds from their chemical structure. Structure-toxicity models can be seen as a special, albeit important, case. Unfortunately, several of the published applications are merely examples of spurious correlations because simple chemical and statistical rules have not been obeyed (1, 2) .
Recently an understanding has emerged of how and when empirical mathematical models can be used in the modeling and prediction of the biological activity (1-3). These models usually involve several variables describing the chemical structure of the compounds. Moreover, although it is sometimes stated otherwise (4) (5) (6) must be formulated for each biologically and chemically similar subset. Consequently, the data analytical problem then is partly one of classification, PARC.
We shall here discuss the application of PARC in the modeling and prediction of toxicity. Some emphasis will be given to pitfalls and commonly made mistakes. This is because the area is of such importance. Mistakes and overstated results may directly affect human safety.
Form of Pattern Recognition Problems and Data Sets
PARC applies when multiple data (variables) are used to characterize a set of "objects," here compounds or mixtures. The objects are divided into two sets, the training set and the test set. The training set is often further divided into several subsets, classes of objects with inherent similarity. Thus the available data have the form shown in Figure 1 .
We here emphasize that data do not appear like this automatically. As the first phase, a given problem must be translated to one that can be handled by PARC. Classes, variables, and objects must be specified or selected according to available knowledge. The subse- quent data analysis is the simplest part of the problem, but we must be aware of the possibilities to analyze various types of data to be able to translate our problem efficiently in the first phase. The scope of PARC data analysis is partly one of classification. The training set data are used to develop mathematical rules which then can be used to assign new objects to one of the classes on the basis of the same type of data measured on these new objects.
In case the training set consists of just a single class, the classification of new objects corresponds to finding out if they are similar to the training class or not.
In the analysis of structure-activity relationships, the simplest level of PARC outlined above-henceforth called PARC level I-is rarely sufficient. One cannot be certain that all compounds, neither in the training set nor in the test set, indeed belong to one of the given classes. The possibility of new unexpected classes must be taken into account, i. e., the possibility that a compound is an "outlier" to the given classes must be considered in the data analysis. Such analysis is PARC level II.
In many applications one desires also to get a quantitative model of the relation between the potency of the compounds and their structure. If this potency is measured by a single variable-here denoted y-we have PARC level III. The structure data X are then used to (a) classify compounds into one of the given classes or as outliers and (b) to predict the value of the activity variable y. When the activity is quantitatively measured by several variables, giving the activity matrix Yg for class g in the training set, we have, finally, PARC level IV. The scope is the same as level III except that all the multiple y-variables enter the models simultaneously. Thus we then have the data shown in Figure 2 .
The natural level for the analysis of structure-activity relationships is, we believe, PARC level IV. This is because a single structural variable rarely is able to capture the complex effects of modifying chemical struc Hence more realistic data sets can now be analyzed in applications of quantitative structure activity relationships (QSAR) including structure-toxicity models. The toxicity of a set of compounds can be measured in several different ways giving multivariate activity data. The "block" of toxicity variables can be modeled in terms of a "block" of a great number of structure descriptor variables. And this for a number of compounds which may be small compared to the number of variables in any or both blocks.
"Biological activity," e. g., toxicity, is usually the result of a complicated system of "fundamental processes." Therefore, several biological measurements and tests are usually needed to "capture" the nature of this activity. Analogously, the modification of chemical structure and its influence on the biological activity needs a substantial number of variables, since the number of possible types of chemical-biological interactions is large. Thus the change of any part of a molecule induces changes in lipophilicity, steric factors, the electron distribution, hydrogen bonds, and so on.
The traditional PARC methods such as linear dis- However, projection methods such as principal components analysis (7, 8) and partial least-squares modeling in latent variables (PLS) (8, 9) can deal with large numbers of both dependent variables (y) and predictor variables (x) and their relationships without increasing the risk for spurious results. This is because the data in each block (Y and X) are separately contracted to a few "latent" variables which then are related to each other.
Since the contraction is made in a statistically controlled way separately for each block, and since only so few latent variables are extracted that are far fewer than the number of cases, the resulting relations between the blocks of variables are significant and the risk for spurious correlations plaguing the traditional methods is small and kept under statistical control.
With these projection methods, QSAR data can now be effectively and appropriately analyzed (10, 11 This problem has now been sorted out and it has been shown that all claims that structure-activity models can be formulated for structurally diverse compounds are erroneous and based on incorrect data analysis and incorrect evaluation of statistical significance levels (2). The only problem remaining is one of psychology. We must accept that the construction of structure-activity models is difficult, demanding profound biological knowledge about the modeled system. Such knowledge often does not exist and therefore the modeling often fails. There is no fast and simple way to obtain information.
Valid Ways To Construct Multivariate Models
We shall discuss below what one can do and cannot do in the context of structure-activity modeling, in particular when the biological activity relates to "toxicity." To facilitate a rational discussion, we divide the QSAR problem into a number of separate subproblems. Though these subproblems are only loosely connected, the data analysis has a strong influence on the earlier parts of a QSAR investigation. In particular, the design of an investigation is strongly affected by the knowledge that data with several toxicity measures (Y) are much more informative than a single measurement and that such multivariate activity data indeed can be related to a multitude of structural data (X).
Modeling in General
The idea of modeling is closely related to the analogy concept. The idea is to construct models which behave analogously to the system we really wish to study and predict. Models are practical because they are simpler to study and thereby even easier to "understand." They are also cheaper and ethically preferable to manipulate and observe.
In toxicity studies, a number of model types can be seen. All of them can with advantage be used "multivariately." The relation between the "measurements" made on the model's system and the "real system" can be qualitative (classification, PARC levels 1 and 2, see above) or quantitative or both. Chain models can also be envisioned as exemplified by type 6. The pertinent system for which we wish to draw conclusions-the "real system" below-usually is man, but often other systems are of interest, e.g., ecological systems, with the implicit assumption that detrimental effects of chemical agents on these systems indicate that they are harmful also for man.
(1) Model: A mathematical description of the chemical structure. Real system: The measured biological activity in one or several tests (in man or in an animal systems or in a cell test system).
(2) Model: Chemical and physical measurements on chemical compounds. Real system: as in 1.
(3) Model: In vitro tests. Real system: An animal, say rabbit, or man.
(4) Model: A combination of in vitro tests and chemical structure description. Real system: as in 3.
(5) Model: One or several animal system. Real system: Man or an ecological system.
(6) Models: Chemical structure (block 1), in vitro tests (block 2), animals (block 3). Real system: as in 5. A multiblock chain model can be organized as, for instance, block 1 --block 2 -* block 3 -> block 4.
We shall here discuss mainly models of type 1 and 2, relations between chemical structure and biological activity. However, the general approach and the data analytical methods is equally applicable to models of types 3-6. The PLS models discussed below can handle chains of blocks with any number from two to about a hundred blocks.
Hard And Soft Models. We distinguish between hard (fundamental) and soft (empirical) models and argue that the latter at present are more suitable for toxicity models because of the general lack of knowledge of the fundamental mechanisms involved.
Hard models incorporate assumptions about the mathematical form of the model, derived from the "fundamental knowledge" about the studied system. Kinetic models in the form of systems of differential equations are typical examples of hard models.
Soft models, in contrast, incorporate as few assumptions as possible, usually only assumptions about homogeneity and continuity of the data. The homogeneity assumption in the present context corresponds to the assumption that the biological data measure "the same mechanism" of toxicity over the set of studied compounds. Hence, empirical models are necessarily local in their nature. Each model is valid oAly for a set of biologically and thereby also chemically similar compounds. Claims that empirical models can be constructed for sets of compounds with diverse structures are wrong as discussed above and based on an incorrect statistical evaluation of sampling artifacts.
The continuity assumption means that a small change in chemical structure shall also cause a small change in the measured toxicity. Though seemingly trivial, this assumption is essential in any kind of empirical modeling.
The lack of assumptions in empirical models is compensated by the use of multivariate data. Several measurements are used to characterize both the biological activity and the structure. These data inserted into the soft model give "patterns" specific for each type of systems. These "patterns" can then in retrospect be used to check if the "fundamental knowledge" is consistent with the actual data. Additionally, the patterns can be used to predict the biological activity (Y) of new compounds from their structural descriptors (X).
Soft multivariate models, below exemplified with the PC and PLS models, can be used to analyze experimental data and make predictions long before sufficient knowledge is available to apply fundamental, hard, models. The knowledge about a system is never complete, in particular not in a research situation. Hence, soft models are the best choice in early stages of an investigation and for new subproblems in older investigations. When the empirical knowledge increases, this can be incorporated into the models, making them less soft and more hard.
The Analogy Assumption. In the present context, one further crucial assumption is made, namely, that of analogy: that the variation in structure can be described by numbers which are derived from chemical standard reactions. Thus, one assumes that the change of a substituent in the studied set of compounds, say from methyl to chloro, is causing a change in toxicity that can be modeled in terms of the same "effects" as in an ensemble of chemical standard reactions. The change from methyl to chloro induces a certain change in (a) pKa of parasubstituted benzoic acids, (b) the distribution between octanol and water of para-substituted phenols, (c) the rate of ester hydrolysis of alpha-substituted acetic acid ethyl esters, and so on. These changes can be described as numerical values in different variables corresponding to (a), (b), and (c), etc. By selecting a sufficient range of chemical standard reactions, we hope to "capture" all effects by which a change in a substituent can change chemical reactivity.
We then assume that the toxicity is affected by the same effects, but in an unknown combination. Thus, toxicity is seen as a chemical reaction, albeit rather complicated. As will be discussed below, the set of standard reaction data can then be combined in a PLS model which well predicts the change in toxicity which takes place when a change is made in the chemical structure. Again, since chemical effects combined differently in different reactions, the models apply only for chemically similar compounds causing toxicity by the same biological mechanism.
A greater variation in chemical structure, and thereby in the way structure influences toxicity, must therefore be handled by an ensemble of disjoint models, one for each subset of similar compounds. For neighboring subsets, the models may be joined by soft relations between the latent variables.
Design, Selection ofCompounds. With any type of models-hard or soft-the selection of what and where to measure is of utmost importance for the later application of the models for predictions. With any model, extrapolations are imprecise fMr outside the domain of the data on which the model was "calibrated." Therefore each structural "factor" must be varied to "span" the domain in which predictions are sought.
As shown by statistical investigations of design strategies, it is extremely inefficient to change one factor at a time in empirical modeling (12) . In the present context of structure-activity models, this means that one must not construct the set of studied compounds by changing one structural element, one substituent, at a time. If, for instance, we have three substituent sites and we can at each site put the four substituents a, b, c or d, an inefficiently selected set would be: aaa, baa, caa, daa, aba, aca, ada, aab, aac and aad. This set gives no information about the joint influence of the three sites on the biological activity. A much better set derived by fractional factorials (12,13) would be aaa, acd, bbd, bda, cbb, cdc, dac and dcb.
The Number of Compounds. With the projection methods discussed here, the relation between the number of objects (here compounds) and variables is unimportant. To span the abstract space of chemical structural variation for a given class of compounds, a certain minimal number of carefully selected compounds is necessary. In case we can divide the chemical structure into a fixed "backbone" plus a number (m) of substituent sites, the minimal set of compunds is 8 x 2-', i.e., 8 for one substituent site, 16 for two, 32 for three, 64 for four sites, etc. The selection of these compounds is made by fractional factorial designs (12, 13) in the variables used as structural descriptors, four to five per site (see below). These numbers may seem large, but we must remember the number of possible compounds which is at least 100"', i.e., 100 millions for the case with four sites.
Biological Data
The characterization of the toxicity or other biological effect of a chemical compound is best made by a multitude of variables. Such multivariate data allow the independent judgment of the quality of the biological variables and also the resolution of these data into different "factors" as discussed below.
In traditional science, there is a strong tendency to try to characterize the state of a system by a single variable. The chemical potential is a typical example from physical chemistry, and LD50 an example from toxicology. The more complicated an investigated system is, however, the more unlikely it is that this single variable is sufficient in a given problem. Thus, in the typical study of relationships between chemical structure and toxicity, one must measure toxicity in several different ways, preferably in several different test systems, to capture most of the different ways the chemical compounds can affect biological systems.
The limitation of the number of different toxicological measures one should include in an investigation is mainly economical. The larger the number of different measurements, the more information one obtains, but at a greater cost. At some point the marginal price of the next increment of information is too high and the practical limit is reached.
Chemical Structure and Its Quantification
To apply PARC data analysis, the variation in chemical structure between the investigated compounds must first be translated to values of variables. The most direct and usually most informative way is to use chemical and physical properties measured on the chemical compounds. Lipophilicity (log P octanol/water), acid-base properties (pKA), solubility in water, IR and NMR spectra, and reactivities in model reactions are often relevant in structure-activity and toxicity studies. We note that to get these measurements, the compounds must actually exist in the real world (models type 2).
In models of type 1, one wishes to construct theoretical models so that predictions can be obtained for new compounds before they are actually synthesized and available for real measurements. If the compounds can be divided into a fixed structural backbone plus substituent sites, this task is reduced to the simpler problem of describing the substituents sitting at the different sites. The description of the electronic type of substituent demands two variables (14, 15) , another variable is needed for lipophilicity (16) , another one or two for steric size (17, 18) ; in total at least four or five structural variables per substituent site are required.
In the more difficult case, when a common backbone cannot be distinguished, there is presently no general way to describe chemical structure. The occurrence of structural fragments has frequently been used in PARC QSAR applications, but this is not recommended, since such variables lack the continuity properties required for PARC. Moreover, their use seems to increase the risk for spurious correlations (2) . Finally, predictions are difficult to make for compounds with new structural fragments not represented in the training set. Wise and Cramer (19) and Marshall (20) have promising approaches to deal with the quantification of the structural variation of flexible molecules, but as yet the experience is not sufficient to recommend these approaches for routine applications.
Quantum mechanical indices and energy levels may be useful both for the simpler case with backbone and substituents and for the case with flexible molecules. Molecular mechanics is possibly useful to calculate conformations of such molecules, but also these latter approaches are still far from routine.
As discussed above, the larger the number of relevant variables that are used to describe the chemical structure, the better. The data analysis is not complicated by a multitude of chemical descriptors.
Var I FIGURE 3. By PC analysis, the objects-rows in X represented as points in a p-dimensional space-are projected down on a few-dimensional hyperplane (left). Algebraically, this corresponds to the decomposition of X into a mean vector plus the product of two matrices T and P plus residuals E (right).
Data Analysis
The PARC methods used in structure-activity and toxicity studies usually are level-one methods; the linear learning machine (LLM), linear discriminant analysis (LDA), or K nearest-neighbor methods (KNN). As discussed above and in the literature (2,3,10,11), these methods are not suitable for these applications. First, they cannot in a statistically appropriate way cope with outliers. Second, LLM and LDA are not applicable when the number of structure descriptor variables (X) exceeds the number of compounds in the training set. Methods of variable selection are then applied which greatly increase the risk for spurious results (1, 2) . In addition, the data are often scaled to enhance the class separation, which also increases the risk for spurious results even with the otherwise robust KNN method.
To formulate quantitative models of structure-activity relations, multiple regression (MR) is commonly used. Since MR has the same unfortunate limitation as LDA and LLM with respect to the number of X variables, stepwise variable selection is also often used here. The resulting correlations are then often not statistically valid because the effect of the variable selection on the statistical significance levels is not taken into proper account (1) . MR cannot simultaneously model several activity variables, which is another reason why it is less useful in the present context. Finally, MR gives unpredictable and little useful results when the X matrix is collinear, which is often the case in QSAR due to the difficulties in applying traditional experimental design (11) .
Projection Methods, Principal Components, and PLS. An efficient way to analyze one or several data tables is to project the tables down on smaller tables with orthogonal columns. With PARC level I and II, the X matrix of each class (denoted by Xq for class g) is projected down on a few column matrix Tg by means of the projection matrix Pg. Geometrically, this is equivalent to representing each object vector as a point in a p-dimensional space (p is the number of x variables) and then modeling the point swarm of each class as a few dimensional hyperplane. This is indicated in Figure 3 for a single class. In statistics this is called principal components (PC) analysis of the class data matrix. This gives a model of the class in terms of the "class middle"-the vector x)-and the direction coefficients of the hyperplane-the matrix P. New objects can be classified as similar to the class or not in terms of their calculated distance in p-space to the class hyperplane. Mathematically, this distance is calculated by a simple multiple regression with the new object data as the "dependent" variable and the rows in the P matrix as predictor variables. Objects far from all class models are labeled as outliers.
We realize that the projections can be calculated regardless of the number of x variables (p) and its relation to the number of objects in a class (ng) least-squares models in latent variables) the projections of the X and Y matrices can be made simultaneously so that also the correlations between the t and u vectors (columns in T and U) are optimized, thereby creating a connection between the two spaces (9, 11) . This gives a model for each class which can be used (a) to classify new objects (compounds) as similar to the class or not and (b) for compounds similar to the class, to obtain predictions of the y data in terms of the connections between t and u (Fig. 4) Asymmetric Nature of the Active-Inactive Classification
In structure-toxicity investigations, the classification problem is often formulated as the discrimination between active (toxic) and inactive (nontoxic) compounds. If one then applies level one PARC, the analysis is likely to fail or give spurious results. This because the problem is not symmetric (21) .
The active class may be well defined structurally and toxicologically and thereby occupies a small regular volume in p-space. The lack of toxicity in the given biological test system, however, is not a class-defining property. Any compound which lacks the proper structural elements needed to trigger the mechanism of toxicity will be nontoxic. Hence, the majority of all billions of compounds will belong to the "nonactive" class. It is clear that in any conceivable space, these nonactive compounds will be randomly distributed. The active class can be modeled, while the "nonactive" class cannot. Level-one PARC methods such as LLM and LDA that try to separate the two classes by a hyperplane will, of course, fail (Fig. 5) . This is one further reason why these methods cannot be recommended for structure-toxicity relationships.
Level two PARC methods such as SIMCA apply also in the asymmetric problem. Provided that the structural descriptors are relevant to the problem, the proper class of active compounds with similar structure can be well approximated by a PC model. The inactive compounds are likely to be situated outside the tolerance interval of this model. Hence new objects can be classified as similar to the active class (toxic) or not (Fig. 6) .
We note one complication with the asymmetric problem formulation. A compound correctly classified as nonsimilar to the active class may be either inactive or active (toxic) according to another mechanism than the training set actives. Thus not-in-active-class does not necessarily mean inactive. This complication follows from the problem formulation and not from the way the data are analyzed. Hence, the problem is the same also in biological model systems. Lack of activity in a cell test battery need not necessarily correspond to lack of activity in vivo, just that the model system does not apply in the same way as before to the presently tested compound. 
Summary of Statistical Requirements
Empirical modeling is based on certain assumptions about the problem formulation and the properties of the data, notably those of homogeneity and continuity. In structure-activity and toxicity modeling, these assumptions can be translated to certain chemical and pharmacological requirements on the problem and the data as listed below. In addition, to give maximum information, the data should be well designed and relevant, both the structural and the biological activity variation should be described multivariately.
Each model should be applied only to a set of structurally and toxicologically similar compounds. If the data set contains structurally and toxicologically diverse compounds, separate models must be formulated for each homogeneous subgroup-proper class. We note that this is no loss of information, since it is very easy to distinguish between structural classes of compounds, this distinction is not the objective of the modeling.
If traditional statistical methods are used for the data analysis, the initial set of variables, before any selection and reduction, must have fewer members than a fourth of the number of compounds in the training set. When the number of variables is larger than this limit, or if there are collinearities in the X matrix, linear discriminant analysis, linear learning machine or multiple regression methods cannot be used unless the data set is reduced by independent means, e.g., by principal components (factor) analysis.
Projection methods such as SIMCA and PLS work also with many variables and collinear data matrices.
If the problem is formulated as active-inactive, a method able to handle the asymmetric problem should be used, e.g., SIMCA.
When the data set is incomplete, i.e., there are missing observations in the X and Y matrices, most data analytical methods except projection methods (SIMCA, PLS), fail.
The variables used for describing the structural variation should be continuous, preferably directly derived from measured data on model systems (pi, sigma and the like).
The biological data should be relevant and precisely measured. A lack of precision in a single variable can be compensated by including several different variables measured on the same system or related systems.
Each class of compounds should have a certain minimum size. If a single substituent site is varied, eight compounds is minimum, 16 for two sites, 32 for three sites, and so on. These compounds should be selected according to an appropriate design, e.g., fractional factorial. It is not correct to change one structural factor at a time in the compound set.
We emphasize that these demands refer to models of type 1 relating theoretical structural descriptors to toxicity data. In models of types 2-6, where both data blocks X and Y consist of measured data, 15 compounds or thereabout in each class is sufficient to develop models in most instances. If several structural fragments can be varied in a class, this variation must still not be made so that one fragment at a time is varied.
Weak Points of Structure-Activity and Toxicity Models
With the availability of modern computerized data analytical methods the weak point in this field is not the data analytical methodology. Provided that the problem is correctly formulated, classes appropriately chosen, variables correctly selected and measured, and compounds correctly chosen to span the structural variation in the classes, the data analysis will extract all available information. Hence, when a QSAR does not give desired results, there is usually something wrong either in the problem formulation, in the design, in the chemical structure desc -ntion, or in the biological data.
The most common error is the one of design, i.e., of compound selection. One structural factor is varied at a time or structurally diverse compounds are included into the same single model.
We still have much to learn about which effects a structural variation can have on chemical reactivity. If we see biological activity as a special case of chemical reactivity, we realize that the description of structure in QSAR is still far from appropriate. Only for rigid compounds with well-defined sites of substitution can we deal fairly routinely with this problem, but even here much development of substituent descriptors relevant for biological applications is needed. With flexible molecules, structure-reactivity and activity modeling is still in its infancy, and validated successful applications are very rare.
The greatest problem, however, is the specification, selection, and measurement of the biological data. To begin with, a good pharmacological model must be developed, a cell or an animal system that models the effects on the system of interest, often man.
Since a model is never an exact copy of a system, there are always imperfections in the predictions based on the model. One way to decrease the magnitude of these imperfections is to combine a multitude of pharmacological and toxicological measurements into the model, i.e., to use a battery of tests. As indicated above, a suitable data analysis with a projection method will twist the battery results in a way optimal for the given problem. We realize that this multivariate approach is difficult to accept because we are all brought up to the belief that the scientific approach is equivalent to search for a single "crucial variable" and to measure that with the highest precision. With the advent of computers and projection methods, however, the latter approach is no longer informationally optimal, but it will take a long time to change the scientific dogma in this respect.
A great difficulty in pharmacological and toxicological modeling is caused by the demand of homogeneitychemical and pharmacological similarity in the mechanism of action-of the studied set of compounds. However, a number of PARC applications based on projection methods have recently been published (10, 11, (22) (23) (24) (25) (26) . In these studies, at least the risk for spurious results was kept under statistical control by avoiding stepwise variable selection and class-separation enhancing data scaling.
Most of the data sets in these applications were to some extent asymmetric; the "nonactive" class usually did not have any systematic data structure that could be modeled. This indicates that an asymmetric data structure is a common consequence of this type of active-inactive problem formulation.
To illustrate the projection methodology, we use a graph from a paper recently published (11). Callen et al. (27) published mutagenicity and toxicity data for seven halogenated hydrocarbons. We contracted the activity data to five y variables, four measuring mutagenicity and one toxicity. The structural variation among the seven compounds was described by eleven x variables, including traditional variables such as molecular refractivity, MR, and lipophilicity (log P) and four quantum-chemically calculated variables (charges and electronegativities of carbon and chlorine atoms, respectively).
The data set (n = 7, p = lix variables, q = 5y variables) is a typical one that cannot be analyzed with traditional data analytical methods. A PLS-analysis gives two highly significant model dimensions, of which the first is shown in Figure 7 . The first structural PLS dimension consists mainly of the traditional variables, MR, log P, etc We know of only one exception in which structurally diverse compounds may be modeled by a single equation, namely, nonspecific toxicity. This is often related to the total lipophilicity of the compound (log P). This total log P may be calculated approximately from fragment constants (ir) (16) . Thus, a model may be constructed which predicts the nonspecific toxicity from the total log P which, in turn, is In conclusion, we can now concentrate on the importhat if not tant parts of structure-toxicity modeling, namely to get respond to relevant biological data, to use an informative way to more than describe the variation in chemical structure, and, not fits will be the least, the design problem to select representative sets of compounds which well map the complicated abto include stract spaces in which predictions are sought.
